Insiderfinancial: Bulova Technologies Group, Inc. Rockets

New Post Public Reply Private Reply Replies (0) Message Board
times2times2
1,177
Insiderfinancial: Bulova Technologies Group, Inc. Rockets Up The Charts
By Jarrod Wesson / in Momentum & Growth, Momentum Stocks, Stocks / on Friday, 02 Jun 2017
https://www.insiderfinancial.com/bulova-techn...ts/123642/
In our last piece, we noted that Bulova Technologies Group, Inc. (OTCMKTS:BTGI) shares had moved up on high volume after its subsidiary BT-Twiss Logistics acquired Global Frozen Trucking Inc, a Pinellas Park, Florida based refrigerated trucking company. More specifically, we said that this subsidiary was an exciting and highly diversified company that had been growing at a high pace by acquiring business opportunities in different sectors. In our opinion, the market started to wake up and was finally celebrating the moves. In this new update, we will make a review of what happened recently and explain another jump that you can see in the following chart. Another acquisition? No, something better, but you need to read until the end.

Source

Recent Developments

Let’s recap a little the company’s background. The company has three operating subsidiaries; BT Twiss LLC, Bulova Technologies (Europe) LLC, and Bulova Technologies Machinery LLC. Bulova Technologies provides munitions, weapon systems, and combat systems and has accumulated expertise in the defense industry. Bulova Technologies Machinery produces CNC products, which can be seen here, which are distributed in the United States and Canada. Finally, BT Twiss is a trucking company with over 105 trailers, and 90 trucks that provide refrigerated trucking services for the food industry and others.

As we promised in our previous report, the Q2 2017 results are out. The company achieved revenues of $6,259,160. Stephen L. Gurba, President, and CEO of BTGI, explained it in the following words:

“We are pleased by the results of this quarter and we look forward to an increase in our operations’ revenue in succeeding quarters.” We are optimistic that revenues of $28,000,000.00 will be achieved by our fiscal year end of September 30, 2017″ Source

And that was more or less the information contained in the press release. As we wanted to offer a deeper assessment, we checked the accounting books here. We saw that the net income was positive for the first time in the first quarter since June 30, 2016, which is positive, but was not noted by the press release. The company is cutting costs. As of September 30, 2016, the net income was $3,021, whereas it was $1,437 as of December 31, 2016. Thus, there seems to be a trend. We checked further and saw that the SG&A expenses were reduced during this time.

How do we explain it? In our opinion, the new company acquired some businesses last year, but it is now when it has worked reducing overhead costs. It was really nicely done, as the whole group is now profitable. Were these numbers responsible for the share price jump? Yes, exactly, the numbers were released on May 31, 2017 and the market celebrated it the same day. In our opinion, these numbers are the result of the acquisitions made in the past, and the results are coming out now. Could this net income uptrend continue? Yes, if the company finds more hidden and unnecessary costs, the net income could grow even more, and may make the share price creep up even more. We could observe the reaction of other investment sites, which noted that the results were not expected. Have a look at this one:

“Investors loved the strong results sending shares of BTGI up a whopping 142.68% to $0.0068 in mid-day trading today on very high volume. To believe these revenue numbers were not expected by the investment community would be an understatement as investors piled in to this quickly growing multi-industry Company that has its toes in the medical, security, technology and transportation industries among other things.” Source

This is not all true. Market participants, who followed this stock, like us knew that the company was preparing something big. We promised that the next 10-Qs were going to be good and this is what finally happened. Have a look at what we said in our last article. We knew that the growth was going to pay off soon.

“We are waiting for the latest 10-Q from the company, which will quiet the skeptics and get the stock moving even higher. This is phenomenal growth for any company. Because of this growth, we believe investors will be looking back wishing they had gotten on board at current levels. Shares will not be trading around the $.01 mark for much longer.” Source

Conclusion

We told our readers in our previous piece that the subsidiary of BTGI, BT-Twiss, was growing at a high pace and skeptics will soon see it reflected in the financial accounts. It turns out we were correct. Why? The company had been working hard to reduce the SG&A expenses. Merging different companies creates many hidden and unnecessary costs. In this case, it seems that the company could find many overlapping expenses. Thus, the net income was positive for the first time in months. This is very positive. Thus, the market pushed up the share price with high volume when the last 10-Q was released. We believe that this is not over and the company may surprise again soon. Hence, be alert. We will be updating our subscribers as soon as we know more.

Bulova Technologies Group Inc. (BTGI) Stock Research Links

BTGI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

DCHFA Appoints Dr. Moreiça Allana-Kim Ortega for Strategic Leadership

Updated Category News Views 325

DCHFA Welcomes Dr. Moreiça Allana-Kim Ortega The District of Columbia Housing Finance Agency (DCHFA) has announced an exciting new direction by creating an Office of Strategic Planning and Performance, under the leadership of Dr. Moreiça Allana-Kim Ortega. This new office is aimed at enhancing the effectiveness of the agency by addressing the evolving needs of housing...

Continue Reading
Cboe Hits Milestone of 1,000 ETFs, Showcasing Growth Trend

Updated Category News Views 120

Cboe Achieves Major Milestone in ETF Listings Cboe Global Markets, Inc. (Cboe: CBOE) has achieved a remarkable feat by surpassing 1,000 U.S.-listed exchange-traded funds (ETFs). This notable accomplishment underscores Cboe's position as a premier venue for innovative actively-managed ETFs. The exchange has welcomed an impressive number of 185 new U.S. ETFs this year,...

Continue Reading
Eat Happy Kitchen Expands Reach with Nationwide Kroger Partnership

Updated Category News Views 1256

Eat Happy Kitchen Expands Retail Presence Nationally In an exciting development for health-conscious shoppers, Eat Happy Kitchen has significantly expanded its reach across the U.S. Nearly 500 stores under the Kroger family umbrella will now feature the woman-owned brand's all-natural line of pasta sauces. This rapid expansion is a testament to the growing demand for...

Continue Reading
ThreeD Capital Reveals December Net Asset Value of $0.76

Updated Category News Views 183

Understanding ThreeD Capital's Recent NAV Announcement ThreeD Capital Inc. is a venture capital firm that carefully evaluates its financial standing to provide clarity to its stakeholders. Recently, the company disclosed that its unaudited net asset value (NAV) per share was valued at $0.76 as of December 31, 2024. This announcement reflects ThreeD’s commitment to...

Continue Reading
Innovative Wealth Planning Tool by Simon Quick Advisors Unveiled

Updated Category News Views 112

Simon Quick Advisors Introduces WealthMetrx™ for Tax Efficiency Simon Quick Advisors, a leading independent wealth management firm, has unveiled a new service called WealthMetrx™. This innovative approach aims to offer clients a comprehensive understanding of their tax profile by transforming intricate data into practical insights. With WealthMetrx™, clients can...

Continue Reading